Community-based intermittent mass testing and treatment for malaria in an area of high transmission intensity, western Kenya: study design and methodology for a cluster randomized controlled trial

This manuscript describes the study design and methodology of a cluster-randomized controlled trial to evaluate a mass testing and treatment approach for malaria transmission reduction in an area of high malaria transmission in western Kenya.

Author: , , , , , , , , , , , , , , , , , ,
Publication date: June 2017
Source: Malaria Journal

Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya

Data is currently being collected regarding the efficacy of higher doses of ivermectin for malaria treatment. If found to be safe, higher doses may contribute to global malaria elimination strategies.

Author: , , , , , , , , , , , , ,
Publication date: November 2016
Source: JMIR

Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial

RTS, S/AS01 was well tolerated when given to children with WHO clinical stage 1 or 2 HIV disease along with high antiretroviral and co-trimoxazole use. Children with HIV disease could be included in future RTS,S/AS01 vaccination programmes.

Author: , , , , , , , , , , , , , , , , , , , , , , , , , ,
Publication date: October 2016
Source: The Lancet Infectious Diseases